SKA-121
SKA-121 Basic information
- Product Name:
- SKA-121
- Synonyms:
-
- SKA-121
- Naphth[2,1-d]oxazol-2-amine, 5-methyl-
- SKA-121 5-Methylnaphtho[2,1-d]oxazol-2-amin
- SKA121,SKA 121
- CAS:
- 1820708-73-3
- MF:
- C12H10N2O
- MW:
- 198.22
- Mol File:
- 1820708-73-3.mol
SKA-121 Chemical Properties
- Boiling point:
- 403.2±38.0 °C(Predicted)
- Density
- 1.302±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMF: 50 mg/ml; DMSO: 50 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml; Ethanol: 10 mg/ml
- form
- powder
- pka
- 4.48±0.30(Predicted)
- color
- brown to dark gray
SKA-121 Usage And Synthesis
Uses
SKA-121 is a selective KCa3.1 activator. SKA-121 exhibits EC50s of 109 nM and 4.4 μM for KCa3.1 and KCa2.3, respectively.
Biochem/physiol Actions
SKA-121 is a KCa3.1 (IKCa1, IK1, KCa4, SKCa4, SK4) subtype-selective small conductance Ca2+-activated K+ channel (SK channel) positive-gating modulator (EC50 = 109 nM/KCa3.1 vs. 8.7 μM/KCa2.1, 6.8 μM/KCa2.2, 4.4 μM/KCa2.3) with 200- to 400-fold selectivity over CaV1.2 as well as representative KVs (KV1.3, KV2.1, KV3.1, and KV11.1) and NaV (NaV1.2, NaV1.4, NaV1.5, and NaV1.7) channels. When applied in vivo, SKA-121 significantly lowers mean arterial blood pressure in wild-type, but not KCa3.1(-/-), normotensive and hypertensive mice (100 mg/kg i.p.). SKA-121 is a more potent and selective KCa3.1 activator than SKA-31 (EC50 = 260 nM/KCa3.1, 2.9 μM/KCa2.1, 1.9 μM/KCa2.2, 2.9 μM/KCa2.3).
in vivo
In blood pressure telemetry experiments, SKA-121 (100 mg/kg i.p.) significantly lowers mean arterial blood pressure in normotensive and hypertensive wild-type but not in KCa3.1-/- mice. SKA-121 can be used as a new KCa3.1 selective pharmacological tool compound despite its relatively short half-life in mice. A lower dose of 30 mg/kg of SKA-121 does not produce significant alterations in MAP. The vehicle, peanut oil/DMSO (9:1 v/v, for SKA-121), does not cause significant alterations in MAP or HR. SKA-121 has a short half-life (~20 minutes), and plasma decay is extremely rapid (21.3±2.4 μM at 5 minutes; 483±231 nM at 1 hour and 53±44 nM at 4 hours). Since SKA-121 is relatively well soluble (logP=1.79) and can potentially be added to drinking water in animal experiments, it orally is also administered, and find that it has an oral availability of roughly 25%[1].
storage
Store at -20°C
References
[1] Coleman N, et al. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1. Mol Pharmacol. 2014 Sep;86(3):342-57. DOI:10.1124/mol.114.093286
SKA-121Supplier
- Tel
- 021-61415566 800-8193336
- orderCN@merckgroup.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 15911056312
- liming@bio-fount.com
- Tel
- meitaochem@126.com
- meitaochem@126.com
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com